Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Tracking antigen-specific CD8⁺ T cells using MHC class I multimers.

Alanio C, Bouvier I, Jusforgues-Saklani H, Albert ML.

Methods Mol Biol. 2013;960:309-326. doi: 10.1007/978-1-62703-218-6_23.

PMID:
23329496
2.
3.

More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.

Dolton G, Tungatt K, Lloyd A, Bianchi V, Theaker SM, Trimby A, Holland CJ, Donia M, Godkin AJ, Cole DK, Straten PT, Peakman M, Svane IM, Sewell AK.

Immunology. 2015 Sep;146(1):11-22. doi: 10.1111/imm.12499. Review.

4.

[MHC tetramers: tracking specific immunity].

Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.

Acta Med Croatica. 2003;57(4):255-9. Review. Croatian.

PMID:
14639858
5.

Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.

Reguzova AY, Karpenko LI, Mechetina LV, Belyakov IM.

Expert Rev Vaccines. 2015 Jan;14(1):69-84. doi: 10.1586/14760584.2015.962520. Epub 2014 Nov 5. Review.

PMID:
25373312
6.

Multimer technologies for detection and adoptive transfer of antigen-specific T cells.

Casalegno-Garduño R, Schmitt A, Yao J, Wang X, Xu X, Freund M, Schmitt M.

Cancer Immunol Immunother. 2010 Feb;59(2):195-202. doi: 10.1007/s00262-009-0778-4. Epub 2009 Oct 22. Review.

PMID:
19847424
7.

In situ tetramer staining.

Skinner PJ, Haase AT.

J Immunol Methods. 2002 Oct 1;268(1):29-34. Review.

PMID:
12213340
8.

Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramers.

Chattopadhyay PK, Melenhorst JJ, Ladell K, Gostick E, Scheinberg P, Barrett AJ, Wooldridge L, Roederer M, Sewell AK, Price DA.

Cytometry A. 2008 Nov;73(11):1001-9. doi: 10.1002/cyto.a.20642. Review.

9.

High-dimensional analysis of human CD8(+) T cell phenotype, function, and antigen specificity.

Newell EW, Lin W.

Curr Top Microbiol Immunol. 2014;377:61-84. doi: 10.1007/82_2013_354. Review.

PMID:
24096316
10.

Making the most of major histocompatibility complex molecule multimers: applications in type 1 diabetes.

Gojanovich GS, Hess PR.

Clin Dev Immunol. 2012;2012:380289. doi: 10.1155/2012/380289. Epub 2012 May 28. Review.

11.

Generation and use of alternative multimers of peptide/MHC complexes.

Hugues S, Malherbe L, Filippi C, Glaichenhaus N.

J Immunol Methods. 2002 Oct 1;268(1):83-92. Review.

PMID:
12213345
12.

MHC class I multimers.

Sun MY, Bowness P.

Arthritis Res. 2001;3(5):265-9. Epub 2001 Jul 2. Review.

13.

Structure and function of major histocompatibility complex class I antigens.

Li XC, Raghavan M.

Curr Opin Organ Transplant. 2010 Aug;15(4):499-504. doi: 10.1097/MOT.0b013e32833bfb33. Review.

14.

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

Sullivan LC, Clements CS, Rossjohn J, Brooks AG.

Tissue Antigens. 2008 Nov;72(5):415-24. doi: 10.1111/j.1399-0039.2008.01138.x. Review.

PMID:
18946929
15.

[MHC-multimers and their application in studies of antiviral immune response].

Karpenko LI, Mechetina LV, Reguzova AIu.

Zh Mikrobiol Epidemiol Immunobiol. 2011 Mar-Apr;(2):112-9. Review. Russian.

PMID:
21598627
16.

The role of the proteasome in the generation of MHC class I ligands and immune responses.

Sijts EJ, Kloetzel PM.

Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9. Review.

Supplemental Content

Support Center